Drug Trial Radar · NCT00216892
Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris
Last checked: Nov 19, 2026Latest source record: Feb 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,032
Actual
Start
Apr 2005
Primary completion
Not stated
Study completion Dec 2005
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- First posted
- Sep 22, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Patients with psoriasis vulgaris of the trunk and/or limbs are randomised to treatment with: 1. 4 weeks of ointment containing calcipotriol and betamethasone dipropionate followed by 8 weeks of calcipotriol cream 2. 4 weeks of (calcipotriol plus betamethasone dipropionate) ointment followed by 8 weeks of calcipotriol cream on weekdays/ (calcipotriol plus betamethasone dipropionate) ointment on weekends 3. 4 weeks of (calcipotriol plus betamethasone dipropionate) ointment followed by 8 weeks of vehicle of calcipotriol cream The objective is to compare the efficacy and safety of the different treatment regimens
Conditions
- Psoriasis Vulgaris
Interventions
Calcipotriol, (calcipotriol + betamethasone)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of regimen (a) versus regimen (c) by % change in PASI at week 12
Locations
7 sites in 7 countries. Site status is shown where the registry gives one.
Universitair Ziekenhuis
Ghent, Belgium
Dermatrials Research Dermatology Centre
Hamilton, Ontario, Canada
Hôpital Nord, Service de Dermatologie
Saint-Etienne, France
Klinikum der Goethe-Universität, Zentrum für Dermatologie und Venerologie
Frankfurt, Germany
Canisius-Wilhelmina Ziekenhuis
Nijmegen, Netherlands
Hospital Mutua de Terrassa Dermatology Service
Terrassa, Spain
Clatterbridge Hospital, Department of Dermatology
Merseyside, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.